Agilent Strengthens Biopharma Growth Prospects With AI Expansion
Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Agilent (A) Stock Looks Below Fair Value On Cash Flow
Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent finalizes Biocare Medical takeover
Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target
Agilent (A) Stock Trades Up, Here Is Why
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Agilent Completes Acquisition of Biocare Medical
Is the Options Market Predicting a Spike in Agilent Technologies Stock?
Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise
How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics
Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics
Research Tools & Consumables Stocks Q1 Results: Benchmarking Agilent (NYSE:A)
Agilent Technologies Q2 2026 Earnings Call: Complete Transcript
Agilent Technologies Inc (NYSE:A): A Quality Growth Play Passes the ‘Caviar Cruise’ Screen
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.